Article

Caroline Desorbay for l'Avenir
Dec 29 ’25

Bronchiolite: l'anticorps monoclonal nirsevimab protège mieux que le vaccin maternel

We found this article at:

www.lavenir.net/actu/2025/12/29/bronchiolite-lanticorps-monoclonal-nirsevimab-protege-mieux-que-le-vaccin-maternel-AAOZF623OBBWBIEEAF6DEX5HP4/

auteur

Get notified of new articles from this auteur

Caroline Desorbay

La Libre, l'Avenir
Follow this authorFollow this authorMore articles